Furthermore, PD‐1 ligand (PD‐L1) expression and CD8+ T‐cell infiltration in tumor‐infiltrating lymphocytes were enhanced after treatment with RAM, which was beneficial to the killing of tumor cells. This evidence concerns the gene CD8A and neoplasm.